Advancing oral drug development with Formulite®


Guard Therapeutics is acquiring Disruptive Pharma and changing its name to Disruptive Pharma AB

Read More
Latest Press Releases
Press releases
  • 22 Sep 2026

    Disruptive Pharma divests GTX platform and retains rights to future royalty and milestone revenues

    Read More
  • 16 Sep 2026

    Tobias Assander joins Disruptive Pharma as Manufacturing and Process Development Lead

    Read More
  • 03 Sep 2026

    Disruptive Pharma to participate in SweDeliver Summit 2026

    Read More
  • 31 Aug 2026

    Disruptive Pharma to attend Nordic Life Science Days 2026

    Read More
Show more
In focus
  • 16 Sep 2025 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read More
  • 17 Oct 2024 / Presentation

    Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"

    Read More
  • 23 Sep 2024 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read More
  • 19 Sep 2024 / Presentation

    Presentation at Pareto Securities' 15th Annual Healthcare Conference

    Read More
Show more
Upcoming events
  • 12 Nov 2026

    Interim Report January–September 2026

    Read More
  • 18 Feb 2027

    Year-end Report 2026

    Read More
Show more